Cogent Biosciences (COGT) market cap

Market cap today
$4.85B

Cogent Biosciences (COGT) has a market cap of $4.85B. At the end of fiscal 2025 (December 31, 2025) its market cap was $4.58B. That is 431.4% higher than the $861.60M of fiscal 2024. Today's figure is 5.8% above the fiscal 2025 year-end. Figures as of 18 Nov 2026, 08:14 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$4.85B
Market cap, fiscal 2025
$4.58B
Change on fiscal 2024
+431.4%
Highest on record
$4.58Bfiscal 2025
Lowest on record
$332.31Mfiscal 2021
Fiscal years on record
52021–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Cogent Biosciences market cap, in more detail

Across the 5 fiscal year-ends on record (2021–2025), the highest was $4.58B in fiscal 2025 and the lowest $332.31M in fiscal 2021.

History · 5 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Cogent Biosciences market cap, year by year

Cogent Biosciences (COGT) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$4.85B—$27.85—
2025$4.58B 431.4% up$35.52128.90M
2024$861.60M 84.0% up$7.80110.46M
2023$468.39M 31.0% down$5.8879.66M
2022$679.03M 104.3% up$11.5658.74M
2021$332.31M—$8.5838.73M
2020——$11.23—
2019——$2.88—
2018——$17.60—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

Market cap at health care companies of similar size

Market cap of Cogent Biosciences and comparable companies
CompanyMarket cap
Teleflex TFX$6.33B
Mirum Pharmaceuticals MIRM$6.00B
Veradermics MANE$5.30B
Grifols GRFS$5.87B
Cogent Biosciences COGT$4.85B
GRAIL GRAL$4.76B

Today's market value as the market data feed reports it, each in the currency its shares trade in.

More on COGT

Cogent Biosciences, figure by figure

Cogent Biosciences (COGT) overview: price, valuation and scorecardAll health care companies by market value

Cogent Biosciences market cap: questions and answers

What is Cogent Biosciences's market cap?

Cogent Biosciences (COGT) has a market cap of $4.85B. At the end of fiscal 2025 (December 31, 2025) its market cap was $4.58B. That is 431.4% higher than the $861.60M of fiscal 2024.

What are the highest and lowest market cap figures on record for Cogent Biosciences?

Across the 5 fiscal year-ends on record (2021–2025), the highest was $4.58B in fiscal 2025 and the lowest $332.31M in fiscal 2021.

How is Cogent Biosciences's market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Cogent Biosciences (COGT) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/COGT/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.